Orbital Therapeutics logo

Orbital Therapeutics Inc.


Orbital Therapeutics Stock

Orbital Therapeutics focuses on developing innovative gene therapies using a proprietary platform designed to enhance the precision and safety of viral vector-based treatments. Their technology aims to address the limitations of current gene therapy approaches, making treatments more effective for a wider range of genetic disorders and diseases.

Management Team

Giuseppe Ciaramell, PhD Co-Founder, CEO
Giles Besin, PhD Chief Scientific Officer
Niru Subramanian COO
Jonahtan Piazza CFO
John Maraganore, PhD Chairman and Co-Founder
Kristina Burow Director and Co-Founder
Carol Suh Director and Co-Founder

Funding Information